AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

被引:50
作者
Farraye, Francis A. [1 ]
Odze, Robert D. [2 ]
Eaden, Jayne [3 ]
Itzkowitz, Steven H. [4 ]
机构
[1] Boston Univ, Sch Med, Boston Med Ctr, Gastroenterol Sect, Boston, MA 02118 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Univ Hosp, Dept Gastroenterol, Coventry, W Midlands, England
[4] Mt Sinai Sch Med, Dr Henry D Janowitz Div Gastroenterol, Dept Med, New York, NY USA
关键词
PRIMARY SCLEROSING CHOLANGITIS; CHRONIC ULCERATIVE-COLITIS; LOW-GRADE DYSPLASIA; POPULATION-BASED COHORT; K-RAS MUTATIONS; CHRONIC CROHNS COLITIS; ADENOMA-LIKE DALMS; 10-YEAR FOLLOW-UP; CANCER-RISK; COLONOSCOPIC SURVEILLANCE;
D O I
10.1053/j.gastro.2009.12.035
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:746 / U438
页数:33
相关论文
共 218 条
[1]  
Aitola P, 2000, INT J COLORECTAL DIS, V15, P167
[2]   Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence [J].
Alberts, DS ;
Martínez, ME ;
Hess, LM ;
Einspahr, JG ;
Green, SB ;
Bhattacharyya, AK ;
Guillen, J ;
Krutzsch, M ;
Batta, AK ;
Salen, G ;
Fales, L ;
Koonce, K ;
Parish, D ;
Clouser, M ;
Roe, D ;
Lance, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (11) :846-853
[3]   Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease [J].
Allgayer, H .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 :10-14
[4]   Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis [J].
Andersen, SN ;
Rognum, TO ;
Bakka, A ;
Clausen, OPF .
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (06) :327-332
[5]   Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations [J].
Andersen, SN ;
Lovig, T ;
Clausen, OPF ;
Bakka, A ;
Fausa, O ;
Rognum, TO .
GUT, 1999, 45 (05) :686-692
[6]   SUCRASE-ISOMALTASE EXPRESSION IN CHRONIC ULCERATIVE-COLITIS AND DYSPLASIA [J].
ANDREWS, CW ;
OHARA, CJ ;
GOLDMAN, H ;
MERCURIO, AM ;
SILVERMAN, ML ;
STEELE, GD .
HUMAN PATHOLOGY, 1992, 23 (07) :774-779
[7]  
[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000279.PUB2
[8]   Chemoprevention of colorectal neoplasia: The potential for personalized medicine [J].
Arber, Nadir ;
Levin, Bernard .
GASTROENTEROLOGY, 2008, 134 (04) :1224-1237
[9]   Family history as a risk factor for colorectal cancer in inflammatory bowel disease [J].
Askling, J ;
Dickman, PW ;
Karlén, P ;
Broström, O ;
Lapidus, A ;
Löfberg, R ;
Ekbom, A .
GASTROENTEROLOGY, 2001, 120 (06) :1356-1362
[10]   Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease:: a population-based cohort study [J].
Askling, J ;
Dickman, PW ;
Karlén, P ;
Broström, O ;
Lapidus, A ;
Löfberg, R ;
Ekbom, A .
LANCET, 2001, 357 (9252) :262-266